Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001079973-25-000412·PLUS THERAPEUTICS, INC.
Schedule 13G ownership disclosure
PLUS THERAPEUTICS INC
Common Stock, $0.001 par value · CUSIP: 72941H509
Event date: 2025-03-04
- Filing-level shares
- 1,209,754.00
- Percent of class
- 9.99%
- S.H.N. Financial Investments Ltd.
Shares: 1,209,754.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001079973-25-000412
- Form type
- SCHEDULE 13G
- Filer
- PLUS THERAPEUTICS, INC.
- CIK
- CIK 1095981
- Filed
- Mar 18, 2025
- Reporting period
- Mar 04, 2025
- Description
- Schedule 13G beneficial ownership